Suchergebnisse - "Personeni, Nicola"

PubPharm (11)

1

Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma

enthalten in: British journal of cancer | 2019

von Mazzaferro, V. | El-Rayes, B. | Droz Dit Busset, M. | +16

CommentIn: Lancet Oncol. 2019 Jan;20(1):e11. - PMID 30473470

2

Tivantinib for second-line treatment of MET-high, advanced hepatocellular carcinoma (METIV-HCC) : a final analysis of a phase 3, randomised, placebo-controlled study

enthalten in: The Lancet. Oncology | 2018

von Rimassa, L. | Assenat, E. | Peck-Radosavljevic, M. | +27

CommentIn: Lancet Oncol. 2018 May;19(5):591-592. - PMID 29625880

3

Assessment of HER2 status in patients with gastroesophageal adenocarcinoma treated with epirubicin-based chemotherapy : heterogeneity-related issues and prognostic implications

enthalten in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association | 2017

von Personeni, N. | Baretti, M. | Bozzarelli, S. | +9

4

Tumor and circulating biomarkers in patients with second-line hepatocellular carcinoma from the randomized phase II study with tivantinib

enthalten in: Oncotarget | 2016

von Rimassa, L. | Abbadessa, G. | Personeni, N. | +17

5

FOLFIRI and Cetuximab Every Second Week for First-Line Treatment of KRAS Wild-Type Metastatic Colorectal Cancer According to Phosphatase and Tensin Homolog Expression : A Phase II Study

enthalten in: Clinical colorectal cancer | 2015

von Personeni, N. | Rimassa, L. | Verusio, C. | +13

6

Molecular determinants of outcome in sorafenib-treated patients with hepatocellular carcinoma

enthalten in: Journal of cancer research and clinical oncology | 2013

von Personeni, N. | Rimassa, L. | Pressiani, T. | +9

7

Tivantinib for second-line treatment of advanced hepatocellular carcinoma : a randomised, placebo-controlled phase 2 study

enthalten in: The Lancet. Oncology | 2013

von Santoro, A. | Rimassa, L. | Borbath, I. | +25

CommentIn: Lancet Oncol. 2013 Jan;14(1):7-8. - PMID 23182626

8

Standardisation of EGFR FISH in colorectal cancer : results of an international interlaboratory reproducibility ring study

enthalten in: Journal of clinical pathology | 2012

von Sartore-Bianchi, A. | Fieuws, S. | Veronese, S. | +13

ErratumIn: J Clin Pathol. 2012 Jul;65(7):674

9

Outcome prediction to erlotinib in gastroesophageal adenocarcinomas : can we improve epidermal growth factor receptor and phospho-AKT testing?

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2007

von Personeni, N.

CommentOn: J Clin Oncol. 2006 Oct 20;24(30):4922-7. - PMID 17050876

10

Epidermal growth factor receptor gene copy number in esophageal cancer and outcome prediction to gefitinib : does intratumoral heterogeneity matter?

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2006

von Personeni, N.

CommentOn: J Clin Oncol. 2006 Apr 1;24(10):1612-9. - PMID 16575012